Europe Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
The Europe Point of Care (POC) Diagnostics Market is projected to grow significantly, reaching an estimated US$ 21,407.3 million by 2031, up from US$ 8,939.5 million in 2024. This growth represents a compound annual growth rate (CAGR) of 13.4% from 2025 to 2031. The market encompasses various segments across key European countries, including the UK, Germany, France, Italy, Spain, and the Rest of Europe, and is primarily driven by the rising prevalence of infectious and chronic diseases, which increases the demand for rapid and accurate diagnostic solutions.
The demand for advanced, user-friendly testing technologies that facilitate timely clinical decisions is a significant factor contributing to market growth. Substantial investments in research and development from both public and private sectors are fostering innovation in POC devices, particularly in areas such as molecular diagnostics and biosensors. Europe benefits from a robust manufacturing base and a well-established healthcare infrastructure, which supports the production and adoption of high-quality diagnostic products. Additionally, supportive government initiatives and heightened awareness regarding the importance of early disease diagnosis further propel the growth of the POC diagnostics market in the region, positioning Europe as a key player in the global market.
Market Segmentation Analysis
The Europe POC diagnostics market is segmented by various categories:
The POC diagnostics market is experiencing a surge in the number of tests available since its inception, with expectations for continued growth driven by new product launches aimed at providing cost-effective care close to patients. Innovations in technology are enhancing the effectiveness of diagnostic devices, particularly in molecular testing. Recent product launches include:
Country Insights
By country, Germany is the largest market in Europe for POC diagnostics as of 2024. The country has seen a significant rise in cancer cases, with approximately 605,805 new cases reported in 2022. Additionally, healthcare challenges such as hospital-acquired infections (HAIs) and late diagnoses of conditions like AIDS are prevalent. The German government is actively working to improve medical conditions, exemplified by initiatives like Gilead Sciences' HIVISION100, aimed at achieving a 95% HIV diagnosis rate by 2025.
Key Players
Prominent companies in the Europe POC diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
The demand for advanced, user-friendly testing technologies that facilitate timely clinical decisions is a significant factor contributing to market growth. Substantial investments in research and development from both public and private sectors are fostering innovation in POC devices, particularly in areas such as molecular diagnostics and biosensors. Europe benefits from a robust manufacturing base and a well-established healthcare infrastructure, which supports the production and adoption of high-quality diagnostic products. Additionally, supportive government initiatives and heightened awareness regarding the importance of early disease diagnosis further propel the growth of the POC diagnostics market in the region, positioning Europe as a key player in the global market.
Market Segmentation Analysis
The Europe POC diagnostics market is segmented by various categories:
- By Product: The market includes segments such as Glucose Monitoring, Infectious Disease Testing, Cardio Metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and others. In 2024, Glucose Monitoring held the largest market share.
- By Glucose Monitoring: This segment is further divided into Blood Glucose Meters, Lancets, and Strips, with Strips leading the market share in 2024.
- By Infectious Disease Testing: This includes HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Testing, Tropical Diseases Testing, Respiratory Infection Testing, and Hospital Acquired Infections. Respiratory Infection Testing was the largest segment in 2024.
- By Cardio Metabolic Testing: This segment includes tests such as Cardiac Troponin (cTn) Test and Myoglobin Test, with the Cardiac Troponin Test holding the largest share.
- By Purchase Mode: The market is divided into Over-the-Counter (OTC) and Prescription, with Prescription products dominating in 2024.
- By Sample Type: The market is segmented into Blood, Urine, and others, with Blood samples being the most prevalent.
- By End User: This includes Healthcare Facilities, Homecare, and others, with Healthcare Facilities leading the market.
- By Healthcare Facilities: This segment is further divided into Hospitals and Clinics, Diagnostic Centers, and others, with Diagnostic Centers holding the largest share in 2024.
The POC diagnostics market is experiencing a surge in the number of tests available since its inception, with expectations for continued growth driven by new product launches aimed at providing cost-effective care close to patients. Innovations in technology are enhancing the effectiveness of diagnostic devices, particularly in molecular testing. Recent product launches include:
- Sysmex Corporation introduced a POC testing system in June 2023 for detecting antimicrobial susceptibility using urine samples from patients suspected of urinary tract infections.
- Cipla Limited launched the Cippoint device in January 2023, which tests for various parameters including cardiac markers, infectious diseases, and metabolic markers, and is CE IVD approved.
- QuantuMDx launched the Q-POC rapid PCR diagnostic system in July 2021, initially for SARS-CoV-2 detection, which is also CE-IVD marked for use in Europe.
Country Insights
By country, Germany is the largest market in Europe for POC diagnostics as of 2024. The country has seen a significant rise in cancer cases, with approximately 605,805 new cases reported in 2022. Additionally, healthcare challenges such as hospital-acquired infections (HAIs) and late diagnoses of conditions like AIDS are prevalent. The German government is actively working to improve medical conditions, exemplified by initiatives like Gilead Sciences' HIVISION100, aimed at achieving a 95% HIV diagnosis rate by 2025.
Key Players
Prominent companies in the Europe POC diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 PEST Analysis
5. EUROPE POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Point of Care Diagnostics Market Forecast and Analysis
7. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. EUROPE POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 Europe
15.1.1 Europe Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Europe Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 United Kingdom: Europe Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 United Kingdom: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 United Kingdom: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 United Kingdom: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 United Kingdom: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 United Kingdom: Europe Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 United Kingdom: Europe Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 United Kingdom: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Germany: Europe Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Germany: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Germany: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Germany: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Germany: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Germany: Europe Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Germany: Europe Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Germany: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 France: Europe Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 France: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 France: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 France: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 France: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 France: Europe Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 France: Europe Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 France: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.4.5.5 Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Italy: Europe Point of Care Diagnostics Market Share - by Product
15.4.5.5.2 Italy: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.4.5.5.3 Italy: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.4.5.5.4 Italy: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.4.5.5.5 Italy: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.4.5.5.6 Italy: Europe Point of Care Diagnostics Market Share - by Sample
15.4.5.5.7 Italy: Europe Point of Care Diagnostics Market Share - by End User
15.4.5.5.8 Italy: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.5.6.6 Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 Spain: Europe Point of Care Diagnostics Market Share - by Product
15.5.6.6.2 Spain: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.5.6.6.3 Spain: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.5.6.6.4 Spain: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.5.6.6.5 Spain: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.5.6.6.6 Spain: Europe Point of Care Diagnostics Market Share - by Sample
15.5.6.6.7 Spain: Europe Point of Care Diagnostics Market Share - by End User
15.5.6.6.8 Spain: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.6.7.7 Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Product
15.6.7.7.2 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.6.7.7.3 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.6.7.7.4 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.6.7.7.5 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.6.7.7.6 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Sample
15.6.7.7.7 Rest of Europe: Europe Point of Care Diagnostics Market Share - by End User
15.6.7.7.8 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 PEST Analysis
5. EUROPE POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Point of Care Diagnostics Market Forecast and Analysis
7. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. EUROPE POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. EUROPE POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 Europe
15.1.1 Europe Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Europe Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 United Kingdom: Europe Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 United Kingdom: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 United Kingdom: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 United Kingdom: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 United Kingdom: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 United Kingdom: Europe Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 United Kingdom: Europe Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 United Kingdom: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Germany: Europe Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Germany: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Germany: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Germany: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Germany: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Germany: Europe Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Germany: Europe Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Germany: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 France: Europe Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 France: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 France: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 France: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 France: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 France: Europe Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 France: Europe Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 France: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.4.5.5 Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Italy: Europe Point of Care Diagnostics Market Share - by Product
15.4.5.5.2 Italy: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.4.5.5.3 Italy: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.4.5.5.4 Italy: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.4.5.5.5 Italy: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.4.5.5.6 Italy: Europe Point of Care Diagnostics Market Share - by Sample
15.4.5.5.7 Italy: Europe Point of Care Diagnostics Market Share - by End User
15.4.5.5.8 Italy: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.5.6.6 Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 Spain: Europe Point of Care Diagnostics Market Share - by Product
15.5.6.6.2 Spain: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.5.6.6.3 Spain: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.5.6.6.4 Spain: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.5.6.6.5 Spain: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.5.6.6.6 Spain: Europe Point of Care Diagnostics Market Share - by Sample
15.5.6.6.7 Spain: Europe Point of Care Diagnostics Market Share - by End User
15.5.6.6.8 Spain: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
15.6.7.7 Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Product
15.6.7.7.2 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring
15.6.7.7.3 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.6.7.7.4 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.6.7.7.5 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Purchase Mode
15.6.7.7.6 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Sample
15.6.7.7.7 Rest of Europe: Europe Point of Care Diagnostics Market Share - by End User
15.6.7.7.8 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
LIST OF TABLES
Table 1. Europe Point of Care Diagnostics Market Segmentation
Table 3. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 37. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 38. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 39. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 40. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 41. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 42. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 43. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 44. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 45. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 46. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 47. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 48. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 49. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 50. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 51. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 52. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 53. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 54. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 55. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 56. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 57. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 58. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 59. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 60. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 1. Europe Point of Care Diagnostics Market Segmentation
Table 3. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 37. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 38. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 39. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 40. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 41. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 42. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 43. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 44. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 45. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 46. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 47. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 48. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 49. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 50. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 51. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 52. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 53. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 54. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 55. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 56. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 57. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 58. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 59. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 60. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
LIST OF FIGURES
Figure 1. Europe Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Europe Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Europe Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Europe Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Europe Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Europe Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Europe Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. Europe Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Europe Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Europe Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 55. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 56. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 57. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. Europe Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Europe Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Europe Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Europe Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Europe Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Europe Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Europe Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. Europe Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Europe Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Europe Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 55. Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 56. Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 57. Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
